Los Angeles Capital Management’s Inhibrx INBX Stock Holding History
Bought
Maintained
Sold
Other funds holding INBX
S
Los Angeles Capital Management's INBX Position: Q2 2026 in Review
Los Angeles Capital Management increased its Inhibrx (INBX) stake by 2,133% in Q2 2026, buying an estimated $209K and bringing the position to 2,188 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #1165.
Los Angeles Capital Management first reported a position in INBX in Q4 2025 and has held it in 3 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.
- Los Angeles Capital Management held 2,188 shares of Inhibrx worth $207K as of Q2 2026.
- Los Angeles Capital Management bought 2,090 Inhibrx shares in Q2 2026, an estimated $209K.
- Inhibrx made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1165 holding.
- Los Angeles Capital Management first reported a position in Inhibrx in Q4 2025 and has held it in 3 quarters since.
- 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.